Literature DB >> 15520647

Conference report--lupus nephritis: diagnosis, therapy, and outcomes.

Sara M Mariani.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15520647      PMCID： PMC1435645     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  22 in total

Review 1.  Chemokines: therapeutic targets for autoimmune and inflammatory renal disease.

Authors:  Vicki Rubin Kelley; Brad H Rovin
Journal:  Springer Semin Immunopathol       Date:  2003-05

2.  Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group.

Authors:  S M Korbet; E J Lewis; M M Schwartz; M Reichlin; J Evans; R D Rohde
Journal:  Am J Kidney Dis       Date:  2000-05       Impact factor: 8.860

3.  Linkage and interaction of loci on 1q23 and 16q12 may contribute to susceptibility to systemic lupus erythematosus.

Authors:  Betty P Tsao; Rita M Cantor; Jennifer M Grossman; Sung K Kim; Noel Strong; Chak S Lau; Chung-Jen Chen; Nan Shen; Ellen M Ginzler; Rose Goldstein; Kenneth C Kalunian; Frank C Arnett; Daniel J Wallace; Bevra H Hahn
Journal:  Arthritis Rheum       Date:  2002-11

4.  Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995.

Authors:  M M Ward
Journal:  Arch Intern Med       Date:  2000-11-13

5.  Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.

Authors:  Frédéric A Houssiau; Carlos Vasconcelos; David D'Cruz; Gian Domenico Sebastiani; Enrique de Ramon Garrido Ed; Maria Giovanna Danieli; Daniel Abramovicz; Daniel Blockmans; Alessandro Mathieu; Haner Direskeneli; Mauro Galeazzi; Ahmet Gül; Yair Levy; Peter Petera; Rajko Popovic; Radmila Petrovic; Renato Alberto Sinico; Roberto Cattaneo; Josep Font; Geneviève Depresseux; Jean-Pierre Cosyns; Ricard Cervera
Journal:  Arthritis Rheum       Date:  2002-08

Review 6.  Treatment for lupus nephritis.

Authors:  R S Flanc; M A Roberts; G F M Strippoli; S J Chadban; P G Kerr; R C Atkins
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 7.  The risk of pregnancy in patients with lupus nephritis.

Authors:  Gabriella Moroni; Claudio Ponticelli
Journal:  J Nephrol       Date:  2003 Mar-Apr       Impact factor: 3.902

Review 8.  The classification of glomerulonephritis in systemic lupus erythematosus revisited.

Authors:  Jan J Weening; Vivette D D'Agati; Melvin M Schwartz; Surya V Seshan; Charles E Alpers; Gerald B Appel; James E Balow; Jan A Bruijn; Terence Cook; Franco Ferrario; Agnes B Fogo; Ellen M Ginzler; Lee Hebert; Gary Hill; Prue Hill; J Charles Jennette; Norella C Kong; Philippe Lesavre; Michael Lockshin; Lai-Meng Looi; Hirofumi Makino; Luiz A Moura; Michio Nagata
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

9.  Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.

Authors:  James A Tumlin; R A Hennigar
Journal:  Semin Nephrol       Date:  2004-05       Impact factor: 5.299

10.  Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.

Authors:  James A Tumlin; Verachai Lohavichan; Randy Hennigar
Journal:  Nephrol Dial Transplant       Date:  2003-07       Impact factor: 5.992
View more
  1 in total

Review 1.  New therapies for systemic lupus erythematosus.

Authors:  F Goldblatt; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.